Literature DB >> 17873907

Transformation, genomic instability and senescence mediated by platelet/megakaryocyte glycoprotein Ibalpha.

Y Li1, J Lu, D Cohen, E V Prochownik.   

Abstract

GpIbalpha, a subunit of the von Willebrand factor receptor, functions during blood clotting to promote platelet adhesion and activation. GpIbalpha is widely expressed, is positively regulated by c-Myc and is essential for the promotion of c-Myc-mediated chromosomal instability. We now show that GpIbalpha is also a classical oncoprotein in which its deregulated expression leads to transformation, reduced growth factor requirements, increased resistance to apoptosis, and, in primary cells, p53-dependent senescence. Finally, GpIbalpha also promotes double-stranded DNA breaks, and induces profound nuclear dysmorphology, indicating that, in addition to its direct transforming function, it displays genotoxicity at several distinct levels. These findings identify novel functions for GpIbalpha and pathways through which c-Myc mediates transformation and global genomic destabilization.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17873907     DOI: 10.1038/sj.onc.1210794

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  8 in total

1.  Widespread genomic instability mediated by a pathway involving glycoprotein Ib alpha and Aurora B kinase.

Authors:  Youjun Li; Fengfeng L Xu; Jie Lu; William S Saunders; Edward V Prochownik
Journal:  J Biol Chem       Date:  2010-02-15       Impact factor: 5.157

Review 2.  Tumor Cell-Induced Platelet Aggregation as an Emerging Therapeutic Target for Cancer Therapy.

Authors:  Wiktoria Strasenburg; Jakub Jóźwicki; Justyna Durślewicz; Błażej Kuffel; Martyna Parol Kulczyk; Adam Kowalewski; Dariusz Grzanka; Tomasz Drewa; Jan Adamowicz
Journal:  Front Oncol       Date:  2022-06-23       Impact factor: 5.738

3.  The c-Myc target glycoprotein1balpha links cytokinesis failure to oncogenic signal transduction pathways in cultured human cells.

Authors:  Qian Wu; Fengfeng L Xu; Youjun Li; Edward V Prochownik; William S Saunders
Journal:  PLoS One       Date:  2010-05-25       Impact factor: 3.240

4.  Point mutations in c-Myc uncouple neoplastic transformation from multiple other phenotypes in rat fibroblasts.

Authors:  J Anthony Graves; Kristi Rothermund; Tao Wang; Wei Qian; Bennett Van Houten; Edward V Prochownik
Journal:  PLoS One       Date:  2010-10-28       Impact factor: 3.240

5.  Modularity of the oncoprotein-like properties of platelet glycoprotein Ibalpha.

Authors:  Youjun Li; Jie Lu; Edward V Prochownik
Journal:  J Biol Chem       Date:  2008-11-18       Impact factor: 5.157

6.  Mitochondrial structure, function and dynamics are temporally controlled by c-Myc.

Authors:  J Anthony Graves; Yudong Wang; Sunder Sims-Lucas; Edward Cherok; Kristi Rothermund; Maria F Branca; Jennifer Elster; Donna Beer-Stolz; Bennett Van Houten; Jerry Vockley; Edward V Prochownik
Journal:  PLoS One       Date:  2012-05-21       Impact factor: 3.240

7.  The deubiquitinase USP21 stabilizes MEK2 to promote tumor growth.

Authors:  Wenjuan Li; Kaisa Cui; Edward V Prochownik; Youjun Li
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

8.  Myc oncogene-induced genomic instability: DNA palindromes in bursal lymphomagenesis.

Authors:  Paul E Neiman; Katrina Elsaesser; Gilbert Loring; Robert Kimmel
Journal:  PLoS Genet       Date:  2008-07-18       Impact factor: 5.917

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.